Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

Glioblastoma (GBM) is the most malignant CNS tumor with a highest incidence rate, and most patients would undergo a recurrence. Recurrent GBM (rGBM) shows an increasing resistance to chemotherapy and radiotherapy, leading to a significantly poorer prognosis and the urgent need for novel treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Binghao, Wu, Jiaming, Li, Huanzhang, Wang, Yuekun, Wang, Yaning, Xing, Hao, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091563/
https://www.ncbi.nlm.nih.gov/pubmed/37046332
http://dx.doi.org/10.1186/s12964-023-01098-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091563/
https://www.ncbi.nlm.nih.gov/pubmed/37046332
http://dx.doi.org/10.1186/s12964-023-01098-0

Ejemplares similares